Sort
4,870 grants matching “glp 1”
RAPID EPITOPE MAPPING BY AFFINITY-MASS SPECTROMETRY
$0Rockefeller University · P41 · FY2001 · RR
Gut Neuroendocrine Cell Signaling and Obesity
$0Rodger A. Liddle · Durham Va Medical Center · I01 · FY2015 · VA
Effectiveness of Hypoglycemic Medications Among Veterans with CKD
$0Christianne L. Roumie · Veterans Health Administration · I01 · FY2022 · VA
Design And Development Of Experimental Therapeutics
$0Aging · Z01 · FY2002 · AG
Comparative and cost effectiveness of diabetes medications
$0Paul R Conlin · Va Boston Health Care System · I01 · FY2023 · VA
G protein mediated mechanisms of beta-cell compensation and failure in type 2 diabetes
$0Michelle E Kimple · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2024 · VA
INCRETIN HORMONE GLP-1, MODE OF GLUCOSE DELIVERY &UPTAK
$0Mayo Clinic Coll Of Medicine, Rochester · M01 · FY2001 · RR
G Protein Mediated Mechanisms of Beta Cell Death Dysfunction and Decompensation in Diabetes
$0Michelle E Kimple · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2021 · VA
Comparative and cost effectiveness of diabetes medications
$0Paul R Conlin · Va Boston Health Care System · I01 · FY2022 · VA
Islet alterations in type 2 diabetes
$0Alvin Carter Powers · Veterans Health Administration · I01 · FY2022 · VA
Enteroendocrine cell reprogramming during intestinal injury
$0Brian David Muegge · St. Louis Va Medical Center · IK2 · FY2022 · VA
Targeting Microvascular Contributors to Impaired Functional Exercise Capacity in Diabetes
$0Jane E Reusch · Va Eastern Colorado Health Care System · I01 · FY2021 · VA
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE
$0Massachusetts General Hospital · M01 · FY2001 · RR
Mechanisms of glucagon-like peptide 1 (GLP-1) in fatty liver disease
$0Frank A. Anania · Veterans Health Administration · I01 · FY2015 · VA
Comparative and cost effectiveness of diabetes medications
$0Paul R Conlin · Va Boston Health Care System · I01 · FY2024 · VA
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
$0Maureen A Gannon · Veterans Health Administration · I01 · FY2025 · VA
CORE--VECTOR CONSTRUCTION
$0Northwestern University · P30 · FY2001 · CA
SGLT2 INHIBITION AND STIMULATIION OF ENDOGENOUS GLUCOSE PRODUCTION
$0Ralph A Defronzo · South Texas Veterans Health Care System · I01 · FY2016 · VA
GLP 1 ON GLUCOSE UPTAKE AND GLUCOSE OUTPUT IN OBESITY
$0Johns Hopkins University · M01 · FY2000 · RR
Design And Development Of Experimental Therapeutics
$0Aging · Z01 · FY2003 · AG
Aging And The Pancreas
$0Aging · Z01 · FY2001 · AG
EFFECT OF GLP 1 ON GLUCOSE UPTAKE &HEPATIC GLUCOSE OUTPUT IN OBESITY
$0Johns Hopkins University · M01 · FY2001 · RR
Islet alterations in type 2 diabetes
$0Alvin Carter Powers · Veterans Health Administration · I01 · FY2021 · VA
Enteroendocrine cell reprogramming during intestinal injury
$0Brian David Muegge · St. Louis Va Medical Center · IK2 · FY2021 · VA
Preclinical Gene Therapy in a Large Animal Model of DMD
$0University Of Pittsburgh At Pittsburgh · U54 · FY2003 · AR